(Q34473830)

English

Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial (English)

1 reference

Europe PubMed Central

2 August 2017

0 references

multicenter clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hans-Christoph Diener

2

object named as

Hans-Christoph Diener

1 reference

Europe PubMed Central

2 August 2017

1

object named as

Charly Gaul

1 reference

Europe PubMed Central

2 August 2017

author name string

Ulrich Danesch

3

1 reference

Europe PubMed Central

2 August 2017

Migravent® Study Group

4

1 reference

Europe PubMed Central

2 August 2017

publication date

3 April 2015

1 reference

Europe PubMed Central

2 August 2017

The journal of headache and pain : official journal of the Italian Society for the Study of Headaches

1 reference

Europe PubMed Central

2 August 2017

16

1 reference

Europe PubMed Central

2 August 2017

516

1 reference

Europe PubMed Central

2 August 2017

copyright license

Creative Commons Attribution 4.0 International

3 April 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/s10194-015-0516-6

0 references

Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Topiramate for the prophylaxis of episodic migraine in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Mitochondrial dysfunction and migraine: evidence and hypotheses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Propranolol for migraine prophylaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

The International Classification of Headache Disorders: 2nd edition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Migraine--current understanding and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Role of magnesium in the pathogenesis and treatment of migraines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Magnesium in the prophylaxis of primary headache and other periodic disorders in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

6 July 2018

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards subcommittee of the American Academy of Neurology and the American Headache Society

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

Use of complementary and alternative medicine in patients suffering from primary headache disorders.

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache.

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

A six-item short-form survey for measuring headache impact: the HIT-6.

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

Topiramate in migraine prevention: results of a large controlled trial

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study.

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

Open label trial of coenzyme Q10 as a migraine preventive.

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

What is a clinically relevant change on the HIT-6 questionnaire? An estimation in a primary-care population of migraine patients

1 reference

https://api.crossref.org/works/10.1186%2FS10194-015-0516-6

21 January 2018

[Effectiveness of chemical, herbal and dietetic migraine prophylactis. An overview of randomized controlled double-blind studies].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

27 October 2018

The effects of magnesium prophylaxis in migraine without aura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4393401

27 October 2018

[Magnesium in migraine. Results of a multicenter pilot study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25916335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25916335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25916335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S10194-015-0516-6

1 reference

Europe PubMed Central

2 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34473830&oldid=1857794465"